Data Analytics Company Informing Clinical Decisions in Molecular Medicine
Scheduled to Present on August 8, 2013
SAN FRANCISCO, July 30, 2013 — CollabRx, Inc. (CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R. Mika, Chief Executive Officer, will present at the 2013 Southern California Investor Conference (SCIC) at 10:30 a.m. (PT), on August 8, 2013, Track 2. The conference will be held at The Island Hotel in Newport Beach, Calif. CollabRx management will be available during the day on August 8 for one-on-one meetings. Please contact your SCIC representative to schedule a meeting.
Investors and other interested parties may access the presentation at http://psevents.net/002/00271/2013-SCIC/?contid=Track-2 . The webcast will be archived for 60 days following the live presentation.
About the Southern California Investor Conference
The Southern California Investor Conference successfully unites investors from all over the nation and the premier growth companies from the region. Southern California features one of the largest and most diverse concentrations of industry leading companies. For registration and information please visit the conference website http://www.californiastocks.com/ or contact the 2013 Chairman Bud Leedom at (858) 829-8688.
CollabRx, Inc. (CLRX) is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.
Investor Relations Contacts:
Thomas R. Mika, CEO
James Carbonara, Regional Vice President